Merck KGaA
OTC:MKGAF

Watchlist Manager
Merck KGaA Logo
Merck KGaA
OTC:MKGAF
Watchlist
Price: 153.11 USD 1.93%
Market Cap: 66.6B USD

Wall Street
Price Targets

MKGAF Price Targets Summary
Merck KGaA

Wall Street analysts forecast MKGAF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MKGAF is 177.27 USD with a low forecast of 139.17 USD and a high forecast of 231.99 USD.

Lowest
Price Target
139.17 USD
9% Downside
Average
Price Target
177.27 USD
16% Upside
Highest
Price Target
231.99 USD
52% Upside
Merck KGaA Competitors:
Price Targets
ORX
Orexo AB
28% Upside
NEULANDLAB
Neuland Laboratories Ltd
53% Upside
002653
Haisco Pharmaceutical Group Co Ltd
76% Upside
MARKSANS
Marksans Pharma Ltd
38% Upside
ZTS
Zoetis Inc
31% Upside
4151
Kyowa Kirin Co Ltd
7% Upside
AVDL
Avadel Pharmaceuticals PLC
0% Downside
4015
Jamjoom Pharmaceuticals Factory Company SJSC
12% Upside

Revenue
Forecast

Revenue Estimate
Merck KGaA

For the last 13 years the compound annual growth rate for Merck KGaA's revenue is 6%. The projected CAGR for the next 4 years is 3%.

6%
Past Growth
3%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Merck KGaA

For the last 13 years the compound annual growth rate for Merck KGaA's operating income is 9%. The projected CAGR for the next 4 years is 2%.

9%
Past Growth
2%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

Net Income Estimate
Merck KGaA

For the last 13 years the compound annual growth rate for Merck KGaA's net income is 12%. The projected CAGR for the next 4 years is 12%.

12%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-35%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MKGAF's stock price target?
Price Target
177.27 USD

According to Wall Street analysts, the average 1-year price target for MKGAF is 177.27 USD with a low forecast of 139.17 USD and a high forecast of 231.99 USD.

What is Merck KGaA's Revenue forecast?
Projected CAGR
3%

For the last 13 years the compound annual growth rate for Merck KGaA's revenue is 6%. The projected CAGR for the next 4 years is 3%.

What is Merck KGaA's Operating Income forecast?
Projected CAGR
2%

For the last 13 years the compound annual growth rate for Merck KGaA's operating income is 9%. The projected CAGR for the next 4 years is 2%.

What is Merck KGaA's Net Income forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for Merck KGaA's net income is 12%. The projected CAGR for the next 4 years is 12%.

Back to Top